Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunomodulation via secretion of anti-inflammatory cytokines and growth factors" is not a specific molecule, receptor, or canonical drug target. Instead, it describes a **broad biological process** in which various cells—primarily immune cells such as macrophages and T cells—secret anti-inflammatory cytokines (e.g., interleukin 10 [IL‑10], transforming growth factor beta [TGF‑β], interleukin 4 [IL‑4]) and growth factors to counteract inflammation, promote tissue repair, and restore homeostasis after injury or infection. These secreted proteins act by binding to their respective receptors on target cells to suppress pro-inflammatory signaling pathways, regulate immune cell activation, inhibit excessive immune responses, and facilitate healing processes. This mechanism is essential for resolving acute inflammation but can be dysregulated in chronic inflammatory diseases or autoimmunity[1][6]. Because this entry refers to a general mechanism rather than a discrete molecular entity (such as a receptor or enzyme), it is not considered an individual therapeutic target. Key points supporting the above assessment: Anti-inflammatory cytokines such as IL‑10 and TGF‑β are secreted by immune cells to resolve inflammation by counteracting pro-inflammatory signals; they play crucial roles in tissue recovery and prevention of excessive immune responses[1]. Growth factors like TGF‑β also contribute significantly to tissue repair following injury through similar paracrine signaling mechanisms[8]. The term "immunomodulation via secretion..." encompasses multiple molecules with overlapping functions rather than one specific protein/receptor that could serve as a canonical drug target. Therefore, this entry should be flagged as incorrect for use as an individual molecular target; instead, focus should be placed on the specific anti-inflammatory cytokines or growth factors themselves when seeking structured information about therapeutic targets.
Modulation of immune cell activity via anti-inflammatory cytokine secretion; Promotion of tissue repair and suppression of pro-inflammatory pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunomodulation via secretion of anti-inflammatory cytokines and growth factors.